More about Gujarat Fluorochemicals Limited
Fundamentals for Gujarat Fluorochemicals Limited
Regulatory Filings for Gujarat Fluorochemicals Limited
Defence Profits Reach Dharavi's Machinists
From COVID Debt to Green Despair: Industrial Discharge Is Destroying India’s Last Prawn Nurseries
The Hidden Cost of India's Electronics Assembly Push: A 40% E-Waste Surge and the Death of Affordable Repair
The Wedding Loan Trap: How India’s Microfinance Boom Turned Housewives Into Ghost Borrowers and Temple Brass Into EMI Cash
Fundamentals for Gujarat Fluorochemicals Limited
Business Operations:
Sector: Basic MaterialsIndustry: Specialty Chemicals
Gujarat Fluorochemicals Limited engages in the manufacture and trading of bulk chemicals, refrigerant gases, fluorochemicals, fluoropolymers, and allied activities in India, Europe, the United States, and internationally. It provides caustic soda, carbon tetrachloride, chlorine, methylene di chloride, hydrochloric acid, sodium hydrogen sulphate, hydrogen gas, fluorspar, chloroform, and anhydrous hydrogen chloride. The company offers its products under the INOFLON, FLUONOX, INOFLAR, INOLUB, and Refron brands. It provides its products to agrochemicals, pharmaceuticals, EV battery materials, and other sectors. The company was formerly known as Inox Fluorochemicals Limited and changed its name to Gujarat Fluorochemicals Limited in July 2019. The company was incorporated in 1987 and is headquartered in Noida, India. Gujarat Fluorochemicals Limited is a subsidiary of Inox Leasing and Finance Limited.
Revenue projections:
Gujarat Fluorochemicals Limited's revenue projections indicate a decrease from last year's performance, which could lead to investor caution. A fall in revenue is likely to negatively impact the company's profitability, causing concern for shareholders who may view this as a signal of declining financial health.
Financial Ratios:
| currentRatio | 0.000000 |
|---|---|
| forwardPE | 42.038643 |
| debtToEquity | 22.475000 |
| earningsGrowth | -0.190000 |
| revenueGrowth | -0.010000 |
| grossMargins | 0.494620 |
| operatingMargins | 0.147010 |
| trailingEps | 59.790000 |
| forwardEps | 85.400000 |
FLUOROCHEM's low Debt-to-Equity ratio means it is not excessively leveraged, implying a reduced financial risk profile. This suggests FLUOROCHEM maintains a well-balanced financial structure, with more emphasis on equity than debt, ensuring greater flexibility and long-term stability.
Gujarat Fluorochemicals Limited's low growth in earnings and revenue indicates that profits could shrink. This signals potential financial difficulties for the company, suggesting that its profitability might be under pressure.
Gujarat Fluorochemicals Limited's negative gross and operating margins point to financial difficulties, as the company is unable to generate profit from its core operations or production. This could signal broader problems in cost management or declining sales.
FLUOROCHEM's forward EPS being higher than its trailing EPS signals anticipated growth in profitability for the current financial year. This suggests that FLUOROCHEM is on track to improve its earnings, outpacing the previous year's performance and reflecting positive market expectations.
Price projections:
FLUOROCHEM's price projections have steadily declined, indicating that analysts are revising their outlook on the company. This downward trend reflects a more cautious perspective on FLUOROCHEM's future growth prospects.
Recommendation changes over time:
The recent buy bias for FLUOROCHEM from analysts signals strong confidence in the stock's potential. This positive sentiment could encourage investors to see FLUOROCHEM as a smart place to invest their money, especially those looking for stable, long-term returns in a well-established company.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
From Lifesaving Drugs to Sick Units: The Hidden Energy Crisis Inside India’s Pharma Clusters
From Price Pressures to Profit Power: The MSME Playbook Redefining India’s Economy
₹90 Crore Bet Signals a Massive Shift in India’s Rural Economy